Wallonia, the place to innovate in health First China-Belgium Innovation Dialogue March 30, 2017 Laurence Timmermans BioWin www.wallonie.be

Wallonia, the place to innovate in health The biopharmaceutical industry is the driving force for growth in the region. It is the main industrial activity in Wallonia in terms of added value; it provides 54% of jobs in the Belgian pharmaceutical sector. Turn over (2015): Euros 5.4 billion Direct jobs (2015): 16,960 (+ 32,000 indirect jobs) Private R&D investments (2015) : Euros 1.2 billion Cumulated private capital raised by SMEs (2005-2016) : Euros 1,150 billion Pharma/Biopharma = 25% of total Wallonia export Average annual employment growth rate since 2006 7,3% - large, medium, small companies combined 12,8% - small & medium companies

Our members 157 innovative SMEs University hospitals with 20 000 beds 11 000 researchers 7 global leaders 400 research units from 5 universities with many research centres Non exhaustive

Key FIGURES - BIOWIN MEMBERS 164 BioWin members classified by technology

SMART SPECIALISATION STRATEGY

BIOWIN’S core activities 43 R&D projects 246 partners EUR 138 million Wal-Dx/EDCA Rad4Med.be Bilateral collaborative agreements (Canada, Massachusetts USA, Alsace France) 17 training projects (EUR M29,6) 15.000 people trained One-stop shopping platform Cell therapy Proton therapy Big data Biobanking network

JUKE Biotech Park (Shanghai) With the support of: Boston Shanghai Europe P JUKE Biotech Park (Shanghai) N Guanzhou international PARTNERSHIPS

Head of international affairs XIE XIE 谢谢 Thank you Your contact at BioWin Laurence TIMMERMANS Head of international affairs Laurence.timmermans@biowin.org BioWin Maison de l’Industrie Rue Auguste Piccard, 20 6041 Gosselies – Belgium Tel.: +32 (0)71 91.92.85 E: contact@biowin.org